Modern management of oesophageal varices

Postgraduate Medical Journal

Volumn 77, Issue 904, 2001, Pages 75-81

  Gow, P J ^a   Chapman, R W ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Liver transplantation; Oesophageal varices; Portal hypertension; Transjugular intrahepatic portosystemic shunt (TIPS)

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCERYL TRINITRATE; ISOSORBIDE MONONITRATE; NITRATE; OCTREOTIDE; PROPRANOLOL; SOMATOSTATIN; TERLIPRESSIN; VASOPRESSIN;

ARTICLE; BLEEDING; CARDIOTOXICITY; CLINICAL TRIAL; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TRANSPLANTATION; META ANALYSIS; MORTALITY; PATHOPHYSIOLOGY; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; PRACTICE GUIDELINE; STROKE;

ALGORITHMS; BALLOON DILATATION; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIVER TRANSPLANTATION; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RECURRENCE; RISK FACTORS; SCLEROTHERAPY;

EID: 0035140175     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.77.904.75     Document Type: Article

References (99)

1. Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension
2. Regulation of inducible nitric oxide synthase and nitric oxide during hepatic injury and fibrogenesis
3. Brachial and femoral artery blood flow in cirrhosis: Relationship to kidney dysfunction
4. Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone
5. Natural history of cirrhosis
6. Incidence of large oesophageal varices in patients with cirrhosis: Application to prophylaxis of first bleeding
7. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices
8. Prospective evaluation of esophageal varices in primary biliary cirrhosis: Development, natural history, and influence on survival
9. The course of patients after variceal hemorrhage
10. Prognostic factors in upper GI bleeding
11. Combined sclerotherapy and operation for the treatment of bleeding oesophageal varices
12. Survival after endoscopic sclerotherapy for esophageal varices in cirrhotics
13. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient
14. Portal pressure, presence of gastroesophageal varices and variceal bleeding
15. The natural history of esophageal varices
16. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment
17. Prediction of variceal hemorrhage by esophageal endoscopy
18. Long-term effects of oral propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis and oesophageal varices
19. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices
20. Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: A prospective, randomized study
21. Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial
22. Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: Results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo
23. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial
24. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: A randomized multicenter trial
25. Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients. Final report of a multicenter randomized trial. The Italian Multicenter Project for Propranolol in Prevention of Bleeding
26. Primary prevention of hemorrhage of esophageal varices by beta-blockade - Generally indicated?
27. Meta-analysis of value of propranolol in prevention of variceal haemorrhage
28. Beta-adrenergicantagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials
29. Propranolol for prevention of first esophageal variceal hemorrhage (EVH): A lifetime commitment?
30. The treatment of portal hypertension: A meta-analytic review
31. Prophylaxis for variceal hemorrhage
32. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: Preliminary report of a randomized controlled trial
33. Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis
34. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis
35. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis
36. A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation
37. A controlled study of the prophylactic portacaval shunt. A final report
38. Prophylactic portacaval anastomosis
39. Prorhylactic portacaval anastamosis in cirrhotic patients with esophageal varices
40. Prognostic significance of bacterial infection in bleeding cirrhotic patients: A prospective study
41. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage
42. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage
43. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A metaanalysis
44. Peptic ulcer in patients with liver cirrhosis: A retrospective endoscopic and clinical study
45. Controlled clinical trial of injection sclerotherapy for active variceal bleeding
46. Complications of endoscopic injection sclerotherapy: A review
47. Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices
48. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis
49. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices
50. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices
51. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial
52. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: Influence on gastropathy, gastric varices and variceal recurrence
53. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients
54. Terlipressin in bleeding esophageal varices: A placebo-controlled, double-blind study
55. Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding
56. Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebocontrolled trial
57. A randomised controlled trial of triglycyl-vasopressin and vasopressin plus nitroglycerin in the control of acute esophageal variceal hemorrhege
58. Terlipressin vs. somatostatin in bleeding esophageal varices: A controlled, doubleblind study
59. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage
60. A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage
61. Esophageal tamponade in the treatment of bleeding varices. A decadel progress report
62. An 8-year prospective experience with balloon tamponade in emergency control of bleeding esophageal varices
63. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes
64. Esophageal tamponade in the management of acute variceal hemorrhage
65. Controversies in the management of bleeding esophageal varices (2)
66. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: Results in 100 patients
67. Intrahepatic portasystemic shunt as a salvage treatment of uncontrolled hemorrhage caused by rupture of esophageal varices in patients with liver cirrhosis
68. Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding
69. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy
70. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis
71. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A final report
72. Propranolol for the prevention of recurrent variceal hemorrhage: A controlled trial
73. Controlled study of propranolol in the prevention of recurrent hemorrhage in cirrhotic patients
74. Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: A multicenter randomized controlled trial
75. Randomized controlled study of propranolol for prevention of recurrent esophageal varices bleeding in patients with cirrhosis
76. Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial
77. Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: Prospective controlled trial of propranolol and sclerotherapy
78. Propranolol et prevention des recidives de rupture de varice oesophagienne du cirrhotique
79. Propranolol in the prevention of variceal hemorrhage in alcholic cirrhotic patients
80. Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial
81. Comparison of three nonsurgical treatments for bleeding esophageal varices
82. Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial
83. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices
84. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices
85. Prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices
86. Ligation plus lowvolume sclerotherapy for high-risk esophageal varices: Comparisons with ligation therapy or sclerotherapy alone
87. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage
88. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial
89. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage
90. A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation
91. A controlled study of the therapeutic portacaval shunt
92. A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis
93. Prospective comparative clinical trial with distal splenorenal and mesocaval shunts
94. Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life
95. Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials
96. Selective shunt in the management of variceal bleeding in the era of liver transplantation
97. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver
98. Partial versus total portacaval shunt in alcoholic cirrhosis. Results of a prospective, randomized clinical trial
99. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation